Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Total Liabilities (2016 - 2025)

InspireMD (NSPR) has 16 years of Total Liabilities data on record, last reported at $14.4 million in Q3 2025.

  • For Q3 2025, Total Liabilities rose 57.26% year-over-year to $14.4 million; the TTM value through Sep 2025 reached $14.4 million, up 57.26%, while the annual FY2024 figure was $10.7 million, 31.68% up from the prior year.
  • Total Liabilities reached $14.4 million in Q3 2025 per NSPR's latest filing, up from $13.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $14.4 million in Q3 2025 and bottomed at $4.7 million in Q1 2021.
  • Average Total Liabilities over 5 years is $7.9 million, with a median of $6.9 million recorded in 2024.
  • Peak YoY movement for Total Liabilities: decreased 2.83% in 2023, then skyrocketed 57.26% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $6.2 million in 2021, then rose by 17.48% to $7.3 million in 2022, then grew by 12.15% to $8.1 million in 2023, then soared by 31.68% to $10.7 million in 2024, then skyrocketed by 33.92% to $14.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $14.4 million in Q3 2025, $13.1 million in Q2 2025, and $10.3 million in Q1 2025.